BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025

Core Viewpoint - BioLife Solutions, Inc. is set to release its 2024 fourth quarter and full year financial results on March 3, 2025, before the market opens, followed by a conference call and live webcast to discuss the results and provide a business update [1]. Company Overview - BioLife Solutions is a prominent developer and supplier of bioproduction products and services specifically for the cell and gene therapy (CGT) market, as well as the broader biopharma markets [3]. - The company's expertise aids in the commercialization of new therapies by providing solutions that ensure the health and functionality of biological materials throughout their lifecycle, including collection, development, storage, and distribution [3]. Investor Relations - Investors can access the conference call via a toll-free number or through the Investor Relations page on the BioLife Solutions website, with a replay available approximately two hours after the call [2]. - The company has designated contacts for media and investor relations, including the Chief Financial Officer and an external investor relations advisor [4].